Concourse Financial Group Securities’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,000
| Closed | -$78.4K | – | 8491 |
|
|
2024
Q4 | $78.4K | Hold |
2,000
| – | – | ﹤0.01% | 1021 |
|
|
2024
Q3 | $78.7K | Hold |
2,000
| – | – | ﹤0.01% | 1022 |
|
|
2024
Q2 | $78K | Hold |
2,000
| – | – | ﹤0.01% | 1010 |
|
|
2024
Q1 | $86.1K | Hold |
2,000
| – | – | 0.01% | 971 |
|
|
2023
Q4 | $92.1K | Hold |
2,000
| – | – | 0.01% | 917 |
|
|
2023
Q3 | $68.3K | Hold |
2,000
| – | – | 0.01% | 960 |
|
|
2023
Q2 | $77K | Hold |
2,000
| – | – | 0.01% | 933 |
|
|
2023
Q1 | $71.6K | Hold |
2,000
| – | – | 0.01% | 968 |
|
|
2022
Q4 | $78.9K | Hold |
2,000
| – | – | 0.01% | 910 |
|
|
2022
Q3 | $72K | Hold |
2,000
| – | – | 0.01% | 836 |
|
|
2022
Q2 | $61K | Hold |
2,000
| – | – | 0.01% | 1007 |
|
|
2022
Q1 | $61K | Hold |
2,000
| – | – | ﹤0.01% | 1071 |
|
|
2021
Q4 | $62K | Hold |
2,000
| – | – | ﹤0.01% | 1198 |
|
|
2021
Q3 | $31K | Hold |
2,000
| – | – | ﹤0.01% | 1511 |
|
|
2021
Q2 | $37K | Hold |
2,000
| – | – | ﹤0.01% | 1428 |
|
|
2021
Q1 | $36K | Hold |
2,000
| – | – | ﹤0.01% | 1355 |
|
|
2020
Q4 | $31K | Hold |
2,000
| – | – | ﹤0.01% | 1312 |
|
|
2020
Q3 | $22K | Hold |
2,000
| – | – | ﹤0.01% | 1334 |
|
|
2020
Q2 | $25K | Hold |
2,000
| – | – | ﹤0.01% | 1223 |
|
|
2020
Q1 | $23K | Hold |
2,000
| – | – | ﹤0.01% | 1192 |
|
|
2019
Q4 | $26K | Buy |
2,000
+1,000
| +100% | +$13K | ﹤0.01% | 1179 |
|
|
2019
Q3 | $9K | Sell |
1,000
-1,000
| -50% | -$9K | ﹤0.01% | 1187 |
|
|
2019
Q2 | $20K | Buy |
2,000
+1,000
| +100% | +$10K | ﹤0.01% | 1254 |
|
|
2019
Q1 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 1523 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5515 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5351 |
|